[Form 4] American Strategic Investment Co. Insider Trading Activity
Michael Joseph LeSanto, Chief Financial Officer of American Strategic Investment Co. (ticker: NYC), reported acquisition of 6,000 restricted Class A common shares on 08/20/2025. The shares were issued under the company's 2020 Omnibus Incentive Compensation Plan and carry a $0 acquisition price in this report, reflecting a compensation grant rather than an open-market purchase.
The restricted shares vest over a four-year schedule beginning June 26, 2025, with 25% vesting each year. Following the reported transaction, LeSanto beneficially owns 11,400 Class A shares in total. The Form 4 was signed on 08/22/2025 by the reporting person.
- Acquisition of 6,000 restricted Class A shares under the 2020 Omnibus Incentive Compensation Plan
- Vesting schedule defined: four years with 25% vesting per annum, promoting longer‑term alignment
- Increased beneficial ownership to 11,400 Class A shares, as disclosed on the Form 4
- None.
Insights
TL;DR Insider received a time‑based restricted share grant totaling 6,000 Class A shares, aligning compensation with long‑term retention.
The reported transaction is a non‑market compensation grant: 6,000 restricted shares issued under the 2020 Omnibus Incentive Compensation Plan, recorded at $0 in the Form 4. Vesting is explicitly time‑based over four years in equal annual installments, which suggests retention incentives rather than immediate dilution from an open‑market sale. The transaction increases the CFO's beneficial ownership to 11,400 Class A shares, a straightforward disclosure with limited direct impact on near‑term capitalization or cash flow.
TL;DR The grant is a standard executive compensation event with multi‑year vesting; governance implications are routine.
This Form 4 documents a compensation issuance rather than a trading decision. The restricted nature and 25% annual vesting over four years align the CFO's interests with shareholder retention objectives and reflect customary incentive plan mechanics. The filing is complete in describing the award and vesting schedule; no exceptions, amendments, or unusual terms are disclosed that would raise governance concerns.